GlassScriptPhysician profile
Kaitlyn L Wong
NPI 1801107818
$8,571.47
in general payments reported to CMS, 2019-2025
34 companies · $585 in 2025
The $585 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,012 · 2020: $966 · 2021: $1,281 · 2022: $1,321 · 2023: $671 · 2024: $1,735 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,887 · Education: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,887.08 |
| Education | $103.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,623.11 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,408.50 | 2019-2025 | Jardiance, Synjardy |
| Glaxosmithkline, LLC. | $635.76 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Gilead Sciences, INC. | $585.71 | 2019-2024 | |
| Lilly USA, LLC | $579.04 | 2019-2025 | Jardiance, Emgality |
| Esperion Therapeutics, INC. | $516.32 | 2021-2024 | Nexletol |
| Amarin Pharma, INC. | $422.57 | 2019-2022 | |
| Exact Sciences Corporation | $405.92 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $392.52 | 2019-2025 | Evenity, Prolia, Otezla |
| Merck Sharp & Dohme LLC | $335.95 | 2019-2022 | |
| Novo Nordisk INC | $330.72 | 2020-2025 | Rybelsus, Ozempic |
| Phathom Pharmaceuticals, INC. | $299.84 | 2024 | Voquezna |
| Abbott Laboratories | $285.79 | 2019-2020 | |
| Hologic Sales and Service, LLC | $125.00 | 2019 | |
| Insmed, INC. | $95.07 | 2024-2025 | Arikayce |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $64.46 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.48 | 2022-2024 | Trulance, Xifaxan |
| Abbvie INC. | $60.54 | 2024 | |
| Ibsa Pharma INC. | $42.00 | 2021 | |
| Eisai INC. | $27.92 | 2025 | |
| Viatris Specialty LLC | $27.27 | 2025 | Yupelri |
| Sunovion Pharmaceuticals INC. | $24.67 | 2019 | |
| Radius Health, INC. | $23.34 | 2019 | |
| Melinta Therapeutics, LLC | $23.32 | 2019 | |
| Alexion Pharmaceuticals, INC. | $22.72 | 2021 | |
| Lupin INC. | $21.71 | 2019 | |
| Pfizer INC. | $20.00 | 2025 | |
| Horizon Therapeutics Plc | $20.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.93 | 2019 | |
| Vbi Vaccine (Delaware) INC. | $15.00 | 2022 | |
| Allergan, INC. | $14.29 | 2019 | |
| Nestle Healthcare Nutrition INC. | $14.20 | 2023 | |
| Intercept Pharmaceuticals, INC. | $14.17 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlyn Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.